Clinical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future small cell lung cancer patients during clinical trials.
Study Type
OBSERVATIONAL
Enrollment
500
Rate of patients who decide to enroll in a small cell lung cancer clinical study.
Time frame: 3 months
Number of small cell lung cancer patients who remain in clinical trial until completion.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.